52.11% | % of shares held by all insiders |
18.91% | % of shares held by institutions |
39.48% | % of float held by institutions |
55 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
BVF Inc. | 7,428,379 | 30 Mar 2022 | 8.90% | 29,713,516 |
Morgan Stanley | 2,004,472 | 30 Mar 2022 | 2.40% | 8,017,888 |
Platinum Investment Management Ltd | 1,062,462 | 30 Mar 2022 | 1.27% | 4,249,848 |
Artal Group S.A. | 1,000,000 | 30 Mar 2022 | 1.20% | 4,000,000 |
Wells Fargo & Company | 491,356 | 30 Mar 2022 | 0.59% | 1,965,424 |
EcoR1 Capital, LLC | 485,005 | 30 Mar 2022 | 0.58% | 1,940,020 |
Renaissance Technologies, LLC | 452,490 | 30 Mar 2022 | 0.54% | 1,809,960 |
Blackrock Inc. | 292,273 | 30 Mar 2022 | 0.35% | 1,169,092 |
Deutsche Bank Aktiengesellschaft | 284,043 | 30 Mar 2022 | 0.34% | 1,136,172 |
Assenagon Asset Management S.A. | 147,435 | 30 Mar 2022 | 0.18% | 589,740 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
iShares NASDAQ Biotechnology ETF | 251,358 | 30 Jan 2022 | 0.30% | 1,111,002 |
SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF | 54,842 | 30 Jan 2022 | 0.07% | 242,401 |
Fidelity NASDAQ Composite Index Fund | 37,118 | 27 Feb 2022 | 0.04% | 151,070 |
ETFis Ser Tr I-Virtus LifeSci Biotech Clinical Trials ETF | 32,852 | 30 Jan 2022 | 0.04% | 145,205 |
ProShares Tr-Ultra Nasdaq Biotechnology Fd | 8,260 | 27 Feb 2022 | 0.01% | 33,618 |